TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

117.20$ -3.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MANE
Line item 2023 2024 2025
– – –
– +21.4% +476.0%
– -20.4% -630.9%
– – –
– – –
– – -100.0%
– +335.2% +163.1%
– +9,455.3% -185.1%
– – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?